机器人平台处理慢性胰腺炎外科后遗症的安全性与可行性
该回顾性研究分析了2009年5月至2017年1月匹兹堡大学39例因慢性胰腺炎后遗症行机器人辅助胰腺切除和/或引流术的患者,结果显示无中转开腹,Clavien III-IV并发症率为13%,无30天或90天死亡,中位住院7天,表明机器人平台安全可行。
要点
- 机器人辅助手术治疗慢性胰腺炎后遗症安全可行,无中转开腹。
- Clavien III-IV并发症率13%,无30天或90天死亡。
- 排除全胰切除后临床相关胰瘘率为7%。
核心结论
- 机器人平台在处理慢性胰腺炎后遗症的复杂胰腺切除术中是安全可行的。
研究设计与样本
- 回顾性审查匹兹堡大学2009年5月至2017年1月前瞻性维护的数据库,纳入因慢性胰腺炎行机器人辅助切除和/或引流术的患者。
主要发现
- 812例机器人胰腺切除和重建中39例为慢性胰腺炎指征,包括11例全胰切除术、8例Puestow手术、4例Frey手术、6例胰十二指肠切除术和10例远端胰腺切除术。
- 中位年龄49岁,41%为女性,最常见病因为特发性胰腺炎(n=16,46%)。
- 中位手术时间324分钟,中位估计失血量250 ml,无患者需中转开腹。
- 5例(13%)患者发生Clavien III-IV级并发症,包括1例再手术;排除11例全胰切除术后,临床相关术后胰瘘率为7%(B级=2,C级=0)。
- 无30天或90天死亡记录,中位住院时间7天。
临床怎么用
- 对于慢性胰腺炎后遗症需行复杂胰腺切除或引流术的患者,可考虑采用机器人平台,但需注意并发症风险。
局限性
- 回顾性单中心研究,样本量有限,仅39例慢性胰腺炎患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIM: The application of minimally invasive surgery to chronic pancreatitis (CP) procedures is uncommon. Our objective was to report the safety and feasibility of the robotic approach in the treatment of surgical sequelae of CP, and provide insights into the technique, tricks, and pitfalls associated with the application of robotics to this challenging disease entity. METHODS: A retrospective review of a prospectively maintained database of patients undergoing robotic-assisted resections and/or drainage procedures for CP at the University of Pittsburgh between May 2009 and January 2017 was performed. A video of a robotic Frey procedure is also shown. RESULTS: Of 812 robotic pancreatic resections and reconstructions 39 were for CP indications. These included 11 total pancreatectomies [with and without auto islet transplantation], 8 Puestow procedures, 4 Frey procedures, 6 pancreaticoduodenectomies, and 10 distal pancreatectomies. Median age was 49, and 41% of the patients were female. The most common etiology for CP was idiopathic pancreatitis (n = 16, 46%). Median operative time was 324 min with a median estimated blood loss of 250 ml. None of the patients required conversion to laparotomy. A Clavien III-IV complication rate was experienced by 5 (13%) patients, including one reoperation. Excluding the eleven patients who underwent TP, rate of clinically relevant postoperative pancreatic fistula was 7% (Grade B = 2, Grade C = 0). No 30 or 90 day mortalities were recorded. The median length of hospital stay was 7 days. CONCLUSIONS: Use of the robotic platform is safe and feasible when tackling complex pancreatic resections for sequelae of chronic pancreatitis.
引用
- Hamad A, Zenati MS, Nguyen TK, et al. Safety and feasibility of the robotic platform in the management of surgical sequelae of chronic pancreatitis. Surg Endosc. 2017. PMID: 29273874. doi:10.1007/s00464-017-6010-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。